A Trial of Rosiglitazone for Ulcerative Colitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Ulcerative Colitis, Inflammatory Bowel Disease
In brief
This is a multicenter, randomized, double-blind, placebo-controlled study evaluating rosiglitazone: 4 mg tablets or placebo tablets administered orally twice daily for 12 weeks. The purpose of the study is to evaluate the efficacy and safety of rosiglitazone in the treatment of mild to moderately active ulcerative colitis. Disease activity will be measured using a standard disease activity index. Calculation of the index requires patients to undergo flexible sigmoidoscopy at the start of the study and at week 12.
Key facts
- Study ID
- NCT00065065
- Run by
- James Lewis
- People needed
- 105
- Starts
- 2002-09-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2018-01-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Atlanta Gastroenterology Associates — Atlanta, Georgia, United States
- University of Chicago Hospitals — Chicago, Illinois, United States
- Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research — Chevy Chase, Maryland, United States
- Maryland Digestive Diseases Research — Laurel, Maryland, United States
- Capitol Gastroenterology Consultants — Silver Spring, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Minnesota Gastroenterology — Plymouth, Minnesota, United States
- Atlantic Gastroenterology Associates — Egg Harbor, New Jersey, United States
- Wake Research Associates — Raleigh, North Carolina, United States
- University Hospitals of Cleveland — Cleveland, Ohio, United States
- The Cleveland Clinic Foundation — Cleveland, Ohio, United States
- Avamar Center for Endoscopy — Warren, Ohio, United States
- University of Pennsylvania - Presbyterian Medical Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.